Clinical Research Directory

Inclusion Criteria: * Adults aged 20 to 80 years. * Diagnosed with drug-resistant epilepsy. * Receiving stable anti-seizure medications for at least 4 weeks prior to enrollment. * Able to provide informed consent. * Willing and able to maintain seizure diaries throughout the study period. Exclusion Criteria: * History of progressive neurological disease. * Severe systemic illness (e.g., uncontrolled cardiovascular, hepatic, or renal disease). * Use of coenzyme Q10 or other mitochondrial supplements within 4 weeks prior to enrollment. * Pregnancy or breastfeeding. * Known allergy or hypersensitivity to coenzyme Q10. * Participation in another clinical trial within the past 3 months.